Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation
针对伴有EGFR 20号外显子插入突变的非小细胞肺癌患者，开展sunvozertinib的遗传生物标志物研究，以评估其临床预后和预测价值。
期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2025.102121.
Yan Xu,James Chih-Hsin Yang,Yanqiu Zhao,Ludovic Doucet,Jianying Zhou,Yongsheng Wang,David Planchard,Yun Fan,Bo Jin,Zhigang Han,Laurent Greillier,Julien Mazieres,Meili Sun,Ying Hu,Xia Song,Cuimin Ding,Lin Wu,Kejing Tang,Li Liang,Yu Yao,Ying Cheng,Yong He,Bruna Pellini Ferreira,François Ghiringhelli,Enriqueta Felip,Joaquim Bosch-Barrera,Anwen Liu,Yan Yu,Xiaorong Dong,Junzhen Gao,D Ross Camidge,Weiqi Nian,Chengzhi Zhou,Runxiang Yang,Thomas John,Bo Gao,Lyudmila Bazhenova,Misako Nagasaka,Jianghong Wang,Xiubao Ren,Fei Xu,Wen Li,Dahai Zhao,Huijie Wang,Si Sun,Jian'an Huang,Xuehua Zhu,Li Zheng,Pasi A Jänne,Mengzhao Wang
